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Abstract
Background: Ribonucleotide reductase is the main control point of dNTP production. It has two
subunits,R1, and R2orp53R2.R1has 5 possible catalytic sitestates(empty orfilled with 1 of4 NDPs), 5
possible s-site states (empty or filled with ATP, dATP, dTTP or dGTP), 3 possible a-site states (empty or
filled with ATP or dATP), perhaps two possible h-site states (empty or filled with ATP), and all of this is
folded into an R1 monomer-dimer-tetramer-hexamer equilibrium where R1 j-mers can be bound by
variable numbers of R2 or p53R2 dimers. Trillions of RNR complexes are possible as a result. The
problemistodeterminewhichareneededinmodelstoexplain availabledata.Thisproblemisintractable
for 10 reactants, but it can be solved for 2 and is here for R1 and ATP.
Results: Thousands of ATP-induced R1 hexamerization models with up to three (s, a and h)A T P
binding sites per R1 subunit were automatically generated via hypotheses that complete
dissociation constants are infinite and/or that binary dissociation constants are equal. To limit
t h em o d e ls p a c es i z e ,i tw a sa s s u m e dt h a ts-sites are always filled in oligomers and never filled in
monomers, and to interpret model terms it was assumed that a-sites fill before h-sites. The models
were fitted to published dynamic light scattering data. As the lowest Akaike Information Criterion
(AIC) of the 3-parameter models was greater than the lowest of the 2-parameter models, only
models with up to 3 parameters were fitted. Models with sums of squared errors less than twice
the minimum were then partitioned into two groups: those that contained no occupied h-site
terms (508 models) and those that contained at least one (1580 models). Normalized AIC densities
of these two groups of models differed significantly in favor of models that did not include an h-site
term (Kolmogorov-Smirnov p < 1 × 10
-15); consistent with this, 28 of the top 30 models (ranked by
AICs) did not include an h-site term and 28/30 > 508/2088 with p < 2 × 10
-15.F i n a l l y ,9 9o ft h e
2088 models did not have any terms with ATP/R1 ratios >1.5, but of the top 30, there were 14
such models (14/30 > 99/2088 with p < 3 × 10
-16), i.e. the existence of R1 hexamers with >3 a-sites
occupied by ATP is also not supported by this dataset.
Conclusion: The analysis presented suggests that three a-sites may not be occupied by ATP in R1
hexamers under the conditions of the data analyzed. If a-sites fill before h-sites, this implies that the
dataset analyzed can be explained without the existence of an h-site.
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Background
Introduction
The dNTP supply system produces dNTPs at rates that
match those demanded by DNA replication and repair.
Withrespecttoriboseringmoieties,it iscomprisedofboth
a de novo system whose substrates are ribonucleoside
diphosphates (NDPs) and a salvage system whose sub-
strates are deoxynucleosides (dNs). The de novo system
includes ribonucleotide reductase (RNR), deoxycytidylate
deaminase (DCTD), and thymidylate synthetase (TS), and
the salvage system includes deoxycytidine kinase (dCK),
thymidine kinase 1 (TK1), deoxyguanosine kinase (dGK)
and thymidine kinase 2 (TK2), see Fig. 1. The dNTP supply
system is important because many anticancer agents target
or traverse it (e.g. gemcitabine, hydroxyurea, triapine,
5-FU) or damage DNA directly (e.g. ionizing radiation,
alkylating agents, oxaliplatin) and thus place demands on
it for replacement dNTPs. In the future, mathematical
models of cancer relevant systems will be needed to
optimize multi-agent anticancer dose timings [1]. For
example, gemcitabine (dFdC, diflourodeoxycytdine) [2]
absorption is rate limited by dCK [3,4], dFdC targets RNR
[5], dFdC resistance isassociatedwith RNRover expression
[6,7], and differential ionizing radiation (IR) sensitivity
that dFdC imparts onto mismatch repair (MMR) defective
cells may be due to mismatches caused by dNTP pool
imbalances caused by RNR inhibition, rather than differ-
ential dFdC incorporation into DNA [8], so mathematical
models of dNTP supply will be needed to optimize dFdC-
IR therapies of MMR defective cancers; MMR defective
Figure 1
The dNTP supply system. Thick lines are fluxes, thin solid lines are activations, thin dashed lines are inhibitions. Key
enzymes are described in the text. An RNR s-site mediated large positive feedback loop ATP Æ dCTP Æ dUMP Æ dTTP Æ
dGTP Æ dATP terminates when dATP binds the R1 a-site to inhibit all 4 RNR reductions. Models of enzymes of this system
will eventually be useful in anticancer drug dose time course optimizations [1].
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[9], gastric [10], pancreatic [11], urinary [12], gynecologic
[13,14] and glioma [15] cancers.
The dNTP supply system is ideal for cancer systems
biology research because, among cancer relevant pro-
cesses, it is perhaps the best understood. This is
important because, intuitively, the more understanding
a mathematical model captures, the more likely it is to
be more useful than a conceptual model. Thus, the dNTP
supply system is well poised to be successfully controlled
better with mathematical modeling than without, and
because of this, this system could become a standard of
success in systems biology; the basis of this argument is
prior success in the use of mathematical models to
improve the control of well understood systems such as
power plants and airplanes.
RNR (NDP Æ dNDP) [16] has two subunits, R1, and R2
or p53R2 [17,18]. On short time scales of seconds to
minutes, RNR is controlled through two R1 regulatory
sites, a selectivity (s-) site that is somewhat analogous to
a radio tuning control knob, and an activity (a-) site that
can be thought of as a volume control knob. Compli-
cated positive and negative dNTP-mediated feedback
loops (Fig. 1) impinge upon these two sites to imple-
ment a sophisticated solution to a challenging dNTP
pool balance regulation problem; if pool balance
regulation performance varies across individuals and
MMR performance also varies, individuals compromised
in both systems may be predisposed to cancer [19]. RNR
functional complexity is mirrored by the combinatorial
complexity of its R1 subunit: its catalytic site can be
empty or filled with 1 of 4 NDP substrates, its s-site can
be empty or filled with ATP, dATP, dTTP or dGTP, its a-
site can be empty or bound by ATP for activation or
dATP for inactivation, it may have an h-site that can be
empty or bound by ATP [20], and all of this is folded by
an R1 monomer-dimer-tetramer-hexamer equilibrium
where R1 j-mers may also be bound by variable numbers
of R2 (or p53R2) dimers. As a result, trillions of R1
complexes are possible if R1, R2, UDP, CDP, GDP, ADP,
ATP, dATP, dTTP and dGTP are all present (in this case
~10
2 R1 monomers implies ~10
12 R1 hexamers) and the
problem then is to determine which are needed in
models to explain the data at hand. To appreciate the
magnitude of the problem, if 10
12 complexes are
possible, the number of possible complete dissociation
constant models is 2 raised to the 10
12 (i.e. 1 followed
by ~300 billion zeros), since each complex, and its
corresponding complete dissociation constant K, can
either be in the model (estimated) or out (set to infinity
if the model hypothesizes that the concentration of the
complex is approximately zero across all of the experi-
mental conditions of the dataset). This huge number of
models is even greater if, in addition to hypotheses that
complete dissociation constants are infinite, hypotheses
that binary dissociation constants equal each other are
also considered. Though this problem is intractable for
10-reactants, 2-reactant solutions are feasible and may
yield insights needed to enable 3-reactant solutions, and
so on.
The R [21] package Combinatorially Complex Equili-
brium Model Selection (ccems) [22] is used here to
automatically generate thousands of ATP induced R1
hexamerization models partitioned into two classes:
those that include model terms of complexes with ATP
occupied h-sites (i.e. models that would support the
existence of h-sites if selected) and those that do not.
Comparisons of the Akaike Information Criterion (AIC)
[23,24] of these two classes of models were then used to
assess the extent of h-site evidence strictly in the ATP-
induced R1 hexamerization dynamic light scattering
(DLS) data in figure 1 of reference [20]. No evidence
was found. As discussed in Kashlan’s review below,
evidence for an h-site may, however, exist under different
experimental conditions.
AS i m p l eE x a m p l e
To introduce concepts of model space generation,
standard models of competitive and non-competitive
inhibition are derived below as instances of models in
two systematically defined model spaces, one of spur
graphs which focus on complete dissociation constants
and hypotheses that they are infinite, and one of grid
graphs which focus on binary dissociation constants and
hypotheses that they are equal.
Spur Graphs
Consider the enzyme-substrate-inhibitor (ESI) models of
Fig. 2. The full spur graph at the top of this figure is
represented by the following total concentration con-
straint (TCC) system of coupled free concentration
polynomials:
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where[ET],[ST]and[IT]aretheknowntotalconcentrations,
or system inputs, [E], [S] and [I] are model dependent free
concentrations,whichcanbe thoughtofas predictedlatent
system state variables, the dissociation constants K are
complete dissociation constants, and implicit in these
equations is the equilibrium concept of mass action,
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reached from free E in a single step and thus every term in
the corresponding equations has only one K parameter in
its denominator, see [25]. The model in Eq. (1) is called a
full model because it is fully parameterized to the extent
that no constraints have yet been placed on its parameters.
Model spaces are then generated from full models by
applying constraints to them. For example, the other spur
graphs in Fig. 2 are obtained from the full spur graph by
applying K = ∞ constraints to remove nodes in the graph,
and thus columns of K terms in Eq. (1), one at a time, two
atatime,andthreeatatime.Eachresultinggraph/modelis
then a hypothesis that some K’s are approximately
infinitely large, or that concentrations of the deleted
complexes are so small, throughout all of the experimental
conditions of the dataset, that they can be approximated as
zero, e.g. the competitive inhibition model, where sub-
strate and inhibitor bind the same site and thus cannot
bind simultaneously, hypothesizes that [ESI] = 0, or
equivalently, that KESI = ∞, and its equations are
0
0
0
=− − −
=− −
=−
[] [ ]
[] [] [] []
[][ ]
[] []
[][
EE
ES
KES
EI
KEI
SS
ES
KES
I
T
T
T I I
EI
KEI
]
[] []
. −
Note that this model corresponds to the full spur graph
less the ESI node/edge and that it can also be viewed as
the pair (KESI = ∞,E q .1 ) .
Grid Graphs
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where underscores in subscripts indicate specific binary
reactions. In grid graphs, because the dissociation
constants are binary, equation terms that represent
complexes of n reactants have n -1K parameters in
their denominators.
Thereisaone-to-onemappingbetweentheK’singridgraph
system (2) and those in spur graph system (1), namely,
KES = KE_S, KEI = KE_I,a n dKESI = KE_IKEI_S or KEI_S = KESI/KEI.
It follows then that (1) and (2) are data-fitting equivalents.
The added value of full grid graph systems such as system
(2) is their ability to spawn new hypotheses that cannot be
generated by corresponding full spur graph systems such as
(1). The additional hypotheses are binary K equality
hypotheses. In the example here there is only one such
hypothesis/model, the non-competitive inhibition model
KE_S = KEI_Swhere inhibitor bindinghas nodetectable effect
on substrate binding.
Solutions
System equations are solved as the steady state of a
parent system of ordinary differential equations (ODEs)
[25], e.g. system (1) is solved by simulation of
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Figure 2
ESI model graphs. The full spur graph at the top generates
the seven models/graphs below it via hypotheses taken one
at a time, two at a time, etc, that dissociation constants are
infinite. The C-shaped grid graph is a data-fitting equivalent of
the full spur graph. It generates the non-competitive
inhibition model to its right where parallel edge binary K’s
are equal.
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the state trajectory is merely algorithmic and thus not a
biophysical path. Free concentration solutions then map
to complex concentrations via mass action laws and
these are then mapped to expected measurements, e.g.
see Eq. (6) below and Eqs. (16-18) in [25].
Results
Limitations
The methods presented here are currently limited to
biochemical systems where one central hub protein
mediates all of the interactions and total concentrations
of the reactants are approximately known exactly. It is
assumed that the latter condition is adequately met in
analyses of data derived from systems that were
reconstituted from purified reactants. If the hub protein
has more than one binding site for the same ligand, as
R1 does for ATP, to interpret model terms, a specified
sequence of site filling must be assumed. This assump-
tion, made due to lack of a better option, may not hold.
Automated model space generation is currently limited
to two-reactant systems.
ATP-induced R1 Hexamerization Models
Full model
To generate a space of ATP induced R1 hexamerization
models, the first step is to pick a full model and the
second step is to apply K hypotheses to it [25]. Full
models that include s, a and h ATP binding sites generate
two classes of models: those that include at least one
occupied h-site complex and that thus support the
existence of an h-site, if selected, and those that do not,
i.e. those that allege that all occupied h-site complex
concentrations are approximately zero and that thus
support claims that the h-site is not needed to explain
the data, if selected. The full model below generates both
of these model types.
Full models place an upper bound on the complexity
and size of the model space and should thus be no more
complicated than needed to answer the question of
i n t e r e s t ,e . g .m o d e l sw i t ha fourth ATP binding site
should not be considered as there is no evidence that
such a site exists. Lower bounds can also be placed on
the simplicity of complexes, and this too can reduce the
size of the model space. Thus, based on the crystal
structure of yeast R1 dimers that shows that the s-site is
created at the R1 dimer interface [26], and based on
dTTP induced R1 dimerization being well represented by
free reactants forming (R1)2(dTTP)2 directly [25] (dTTP
binds only at the s-site), it is reasonable to assume that
R1 oligomer s-sites are always fully occupied (i.e. that
oligomers cannot form without full s-site occupancy)
and that R1 monomer s sites are always unoccupied (i.e.
that the s-site does not exist in R1 monomers). With
these restrictions, denoting ATP and R1 by X and R
respectively, and using
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the full spur graph system equations are:
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where, in each equation, first sum limits assume s-sites
cannot be bound in monomers and other sum limits
assume s-sites must be bound in oligomers; here X = ATP
is used because a = dATP and A = ADP are being reserved
for subsequent RNR models and R
jX
i is used instead of
RjXi to stress connections to polynomials.
Interpretations
The hub protein monomer complex RX can be inter-
preted as X bound to either the a-o rh-site. Because the a-
site is known to exist, a-site binding will be assumed.
RXX is then a monomer with both the a-a n dh-sites
occupied. For oligomers, in addition to all of the s-sites
being prefilled, it is assumed that: R
2X
2 through R
2X
4,
R
4X
4 through R
4X
8,a n dR
6X
6 through R
6X
12, have zero
to full a-site occupancies and no h-site occupancies, and
that R
2X
5 and R
2X
6,R
4X
9 through R
4X
12,a n dR
6X
13
through R
6X
18, have partial to full h-site occupancies in
addition to completely filled a-sites (and s-sites). Model
inferences will be based on these interpretations.
Output linkage
The fitted output measurements are mass-weighted
average protein masses
y
Mj R jT
j
RT
= =
∑
+
1
2
1
6
[]
[]
ε
(6)
where [RjT] is the total j-mer concentration (i.e. the sum
of the concentrations of all j-mer hub protein com-
plexes),
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6
is the total hub protein concentration, M1 is the mass of
a monomer (90 kDa for the R1 subunit of RNR), ε is
noise with constant variance and zero mean, and the j
2
in the numerator includes one factor of j because the
mass of a j-mer is j times that of a monomer, and
another factor of j because light scattering is propor-
tional to mass; ligand masses are treated as negligible
relative to protein masses.
Implementation
Nonlinear least squares was used to fit the models. The
fitted models were then rank ordered by their AICs [24].
Because the number of data points N is small at 15, the
small sample size corrected version of the AIC was used:
AIC = 2*P +2 * P(P+1)/(N-P-1) + N*log (2π)+N*log
(SSE/N)+N where P is the number of estimated
parameters (including the variance) and SSE is the sum
of squared errors [24]. In parameter optimizations (i.e.
SSE minimizations, see Methods) the initial complete
dissociation constant values were 100 μMr a i s e dt ot h e
sum of the powers of the numerators in Eq. (4) minus
one, i.e. j + i -1 .T h i sw a sc r i t i c a l ,a si ti n c r e a s e dt h e
number of models that converged from roughly 10%
(when 1 μM was used uniformly) to nearly 100%.
Models were fitted in parallel in a load balanced manner
using R [21]; the R package ccems uses the R package
snow (small network of workstations) to accomplish
this. R scripts that were used to produce the results in this
and the accompanying paper are available as examples in
the papers directory of ccems.
Spur graphs
The number of complexes represented in Eq. (5) is 2 +
5+9+1 3=2 9a n dt h i si m p l i e st h a tt h en u m b e ro fs p u r
models is 2
29 = ~500 million. Relevant here, however, is
the number of 1-, 2- and 3-parameter models. There are
29 single-edge models, 406 (29 choose 2) two-edge
models, and 3654 (29 choose 3) three-edge models. The
lowest AIC of the 3-parameter models (144.4) was
higher than the lowest AIC of the 2-parameter models
(142.7), so 4-parameter models were not fitted; as
parameter numbers increase AICs typically first decrease
as SSEs decrease, but then rise and continue to rise due to
over-parameterization.
Grid graphs
Binary dissociation constants that are alleged equal to
one another must be defined on a per site basis in terms
of koff/kon. For example, using the equilibrium property
that net fluxes between any two complexes must vanish,
for a-sites in tetramers, the on and off fluxes of the 1
st
ligand yield
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where factors of 1 and 4 arise because there is 1 occupied
site for the dissociation reaction and 4 unoccupied sites
for the association reaction, respectively. Similarly, for
second, third and fourth ligand bindings to a tetramer a-
site, the per site binary dissociation constants K are:
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Similar arguments apply to h-sites, with X
i+j replacing X
i
in j-mers.
To introduce a few additional concepts in their simplest
forms, the next two paragraphs consider dTTP induced
R1 dimerization. That not all K equality hypotheses take
the form K = K’ is seen in the penultimate column of the
n-shaped graph pairs in the top half of Fig. 3
where K
2
R_t =[ R ]
2[t]
2/[Rt]
2 =K RR_tKRRt_t = [RR][t]
2/
[RRtt]; here t denotes dTTP. This graph pair can,
however, be restated as the equivalent K = K’ E-shaped
graph pair shown in the corresponding positions below
it. Though earlier work focused on E-shaped graphs [25],
based on the paragraph that follows, it suffices to
consider only n-shaped graphs and natural extensions
thereof (e.g. see Fig. 4).
The first two columns ofK equalitymodels/hypotheses in
Fig. 3 are plausible, as a protein could be so rigid that a
ligand binding site is unchanged with respect to binding
affinity regardless of other bindings (first column) and
t h i sc o u l db et r u ew i t h i nj-mers but not between them
(second column). The third column hypotheses are less
likely, however, as they claim that binding of R (to R),
whichismassive relative toligandandthusmore likely to
cause alterations upon binding, causes no change in
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to the dimer alters the dimer structure enough to change
ligand binding at the second site. Continuing, fourth
column hypotheses are even less likely, as they claim that
the first ligand binds dimer differently than monomer,
yet, after it binds, by chance, the second ligand binding
energy exactly equals the amount needed for the product
of these K’s to equal the square of the monomer ligand K.
Equivalent E-shaped graphs (same column) support this
claim of unlikelihood, as they claim that although
dimerization energies are different between R + R and
Rt + R, they somehow return to the R + R value when both
reactants are Rt. Finally, in the fifth column, it would be
remarkable if ligand binding to free dimer differs from
ligand binding to free monomer, yet somehow, binding
ofthefirstligandreturnstheunoccupieddimersubunitto
a state indistinguishable from that of the free monomer
(with respect to its ligand binding affinity). The third and
fifth columns can be interpreted in terms of rigid
asymmetricdimerswhereonesubunitholdsitsmonomer
shape and the other has a different shape with either
tighter (fifth column) or weaker (third column) ligand
binding. From this perspective, it is very unlikely that all
of the dimerization induced shape changes (deformation
energies) would fall strictly onto one of two identical
subunits. Thus, the grid model space used here will only
include K equality hypotheses that are analogous to the
first 2 columns in Fig. 3, and it suffices to consider
n-shaped graphs.
Within a site type, binary K’so fj-mers can be depicted as
threads hanging from a curtain rod as shown in Fig. 4. In
the accompanying paper, binary K equalities in contig-
uous stretches within threads are considered. Here, each
thread is homogeneous in its binary K value (i.e. only
full thread length contiguous stretches are considered)
and K equality models are instead generated by
considering thread K values as independent of other
threads (top 2 rows in Fig. 4), infinite (graphs with
missing threads), or equal to those of other threads of
t h es a m es i t et y p e( b o t t o m3r o w si nF i g .4 )w i t h i n
contiguous stretches of threads, the idea being that if one
protein oligomerization step alters a ligand K,i ti s
unlikely that an additional step would return it to one of
its previous values.
Figure 3
dTTP-induced R1 dimerization K equality models.
The n-shaped graphs are equal to their corresponding
E-shaped graphs below them. The rightmost three columns
are very unlikely (see text). R = R1, t = dTTP and edges
marked = or – are alleged equal.
Figure 4
K equality RX model space. The graphs shown are the
same for both a-a n dh- s i t em o d e l s .T h et o pt w or o w sh a v e
independent threads and the bottom two rows have at
least two threads that have equal binary K values indicated
by =, –, or x. Bridge edges in the horizontal bars of each
graph (i.e. the curtain rods) are spur edges from the hub,
rather than binary K. Left to right, threads on curtain rods
correspond to monomers, dimers, tetramers and hexamers.
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(page number not for citation purposes)Since R binds R to form R
2 via one protein surface, and
s i n c ei ti sl i k e l yt h a tR
2 binds R
2 and R
4 using two
different protein surfaces (or patches thereof), no
hypotheses of K equivalence will be considered between
the saturated s-site complexes R
2X
2,R
4X
4 and R
6X
6 (i.e.
complexes in the curtain rods in Fig. 4). Thus, all of the K
equality hypotheses explored will be with respect to
ligand binding site constants in threads.
The binary K equality model space of interest here is the
product of a space of a-site models and a completely
analogous space of h-site models. The 32 models shown in
Fig. 4 thus imply a K equality space of 1024 models. If
thread head nodes within curtain rods are allowed to
remain in models where all other nodes in the same thread
have infinite K, the number of models increases: models
missing hexamer threads split into two models (there are 8
of these in Fig. 4) and models missing both tetramer and
hexamer threads (there are 3 of these in Fig. 4) split into
four models. The totalnumber of grid models is then (32 +
8+9 )
2 =4 9
2 = 2401.
Models that contain hexamer terms
Since external data [27] confirms ATP induced R1
hexamerization, the model space was reduced to only
models that contain at least one hexamer term. This
reduced the number of grid models with 2 and 3
parameters to 2 and 15 (from 7 and 36) and the number
of spur models with 1, 2 or 3 parameters to 13, 286 and
3094 (from 29, 406 and 3654), i.e. the number of
models is now 17 + 3393 = 3410.
Competitive models
Of 3410 ATP-induced R1 hexamerization models auto-
matically fitted to the DLS data [20], four failed to
converge (these all involved X
17 and X
18), 966 (Fig. 5B)
converged but had singular Hessians (12 and 954 of
these were 2- and 3-parameter models and all had
infinite upper confidence limits in all parameters) and of
the remaining 2440 fits (Fig. 5A), 1200 had no infinite
upper bounds, 680 had 1 of 3, 91 had 1 of 2, and 369
had 2 of 3. Models with no infinite upper bounds
comprised 64%, 6% and <1% of the lowest to highest
AIC clusters shown in Fig. 5A. To purge the space of
problematic models (e.g. those that were either incorrect
or sensitive to initial parameter values), the space was
reduced to models with SSEs that were less than twice
the minimum SSE of the fitted models. AICs of the
resulting 2088 models are shown in Figs. 5C and 5D.
h-site existence
Fig. 6A shows normalized AIC densities of the models in
Figs. 5C and 5D partitioned into two groups, those that
do not represent any complexes that have occupied
h-sites (508 models) and those that do (1580 models).
That these densities differ is apparent by inspection, a
Kolmogorov-Smirnov p < 10
-16 and by 28 of the top 30
models not including an h-site term, i.e. 28/30 > 508/
2088 with p < 1 × 10
-15. The densities were then
decomposed into models with <3 parameters (6B), 3
parameters (6C) and singular Hessians (6D). In each
case the same conclusion held, the DLS data did not
support the existence of an h-site.
Fig. 7 shows the fits of only the 1-parameter models.
The model R
6X
8 fits the data the best and is
immediately flanked by R
6X
7 (less steep) and R
6X
9
(steeper) which also fit reasonably well, but beyond
these, the fits become noticeably poorer; since these
models all have the same number of parameters, AICs
in the legend reflect SSEs and the gap between the 3
rd
and 4
th model thus reflects a lack of fit. That R
6X
6 is a
poor fit supports the assumption that s-sites are pre-
filled, and that R
6X
10 is a poor fit supports a hypothesis
that only 1 to 3 hexamer a-sites are filled. That R
6X
11
and higher models provide worse and worse fits with
increasing numbers of bound ATP supports the Fig. 6
conclusion that this dataset does not support the
existence of an h-site.
Figure 5
AIC model densities versus AIC model rank. A) and
C) show models that had non-singular Hessians (matrices of
objective function second derivatives) at their optimums;
B) and D) are models with singular (determinant = 0)
Hessians, i.e. models that converged onto likelihood surfaces
that were flat in one direction. C) and D) show 1613 and
475 models with SSEs < twice the minimum SSE.
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(page number not for citation purposes)Fits of the top 3 models are shown in Fig. 8 and their
parameter estimates are given in Table 1. The second of
these is a 2-parameter model that differs from the other
two in that it uses its second parameter to avoid its
obligation to reach an average mass of 540 kDa in the
limit of large [ATP]; when this model was extrapolated to
[ATP] = 1 M (Fig. 9) the predicted average mass in this
limit was 180 kDa. It was conjectured then that
complexes with the highest ratios of ATP bound per R1
completely dominate the distribution in the limit of
high ligand concentrationsa n dt h a to n l yi nc a s e so f
maximum ratio ties does a balance result (i.e. that the
system’s objective in this limit is to partition as much
ATP as possible away from its free form and into a
bound form). Representative models of both a balance
and of hexamer dominance support this conjecture
(Fig. 9). If it is asserted then that the ATP per R1 ratio
cannot decrease as higher R1 oligomers are formed, the
space of 2088 models reduces to 1420 models, but the
calculations of Fig. 7 still yield the same conclusion, i.e.
no h-site existence (Fig. 10). If the ratio is forced to
strictly increase with oligomerization, the number of
models is 1287, and again, the same conclusion holds
(plots not shown).
Unoccupied a-sites
The space of 2088 models contains 99 models that do not
have any terms with ratios of ATP bound per R1 > 1.5 (i.e.
models consistent with ≤ 50% a-site filling in oligomers).
Of the top 30 models, however, there were 14 such
models,whichissignificant,14/30>99/2088withp<3×
10
-16. In the reduced spaces of 1420 and 1287 models (of
the previous paragraph), the proportions are 15/30 > 75/
Figure 6
Normalized AIC densities of models with SSEs less than twice the minimum. A) The models of Figs. 5C and 5D.
There are 508 (1580) models without (with) an occupied h-site. B) The 1- and 2-parameter models of A). C) The 3-parameter
models of A). D) The models in A) that have singular Hessians (i.e. the 475 models in Fig. 5D). In all cases a difference in h-site
hypothesis densities is supported by a two-sample Kolmogorov-Smirnov test, P < 10
-15 ( A ,C ,D )a n dP<1 0
-5 (B).
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(page number not for citation purposes)1420and 13/30> 54/1287, whichalso yield p < 3× 10
-16.
Thus, this dataset does not support the existence of
hexamers with >3 a-sites occupied by ATP. It should be
noted that this statement implies a lack of h-site evidence
if a-sites fill before h-sites.
In the spaces of 1420 and 1287 models, the top 2 models
are R
6X
8 and R
6X
9. If the 13 single edge spur models are
fitted with M1 of Eq. (6) estimated, a probability p thatR1
is capable of oligomerizing estimated (in Eq. 5 p would
then multiply [RT]), or both, the top 3 models are R
6X
9,
R
6X
8 and R
6X
10 ( s e eF i g .1 1 ) ,i . e .t h em a i nc l a i mi ss t i l l
supported but subsequent studies may find that a 4
th
hexamer a-site can also be filled by ATP.
Discussion
No terms higher than R
6X
9 were needed to explain the
ATP induced R1 hexamerization data found in figure 1 of
reference [20]. If s-sites fill before a-sites, this implies
that ~1/2 of the hexamer a-sites are not bound by ATP
under the experimental conditions of this dataset. If
h-sites fill after a-sites, this also implies that h-sites need
not exist to explain this dataset. Since the s-site is at the
dimer interface in yeast [26], and since it is reasonable
that hexamers form as trimers of dimers, it is likely that
s-sites do fill first.
Figure 7
Fits of the 1-parameter models. The legend in the plot
indicates the model order ranked by AICs (values shown).
The top 5 models are indicated by thicker lines. Beyond 5 or
more a-sites occupied by ATP and with increasing numbers
of h-sites occupied, the fits become worse and worse.
Figure 8
Top 3 fits to the data of Kashlan et al.[ 2 0 ] .A) Fits of the top 3 models. The second model uses its dimer term to capture a
slightdownturninaveragemassathigh[ATP](seeFig.9),consistentwithitsgeometricmeanbindingconstantbeinggreaterthan
that of the hexamer term in Table 1. Not shown in this plot is the point (0 μM, 90 kDa) which all models fit perfectly if M1 =9 0
is fixed (as it is here) rather than estimated. B) Residuals of the top model R6X8. The reduced variance and positive mean of the
first 4 residuals may be due to bias arising from prior knowledge that the monomer is 90 kDa and thus too prior knowledge that
the average mass must increase from 90 kDa. Non-weighted least squares gives less weight to these 4 points which,
coincidentally, is advantageous given these suspicions. PlotDigitizer (Methods) was used to obtain the data from a pdf of the
original paper, and as this step involves human intervention, it too may have introduced some bias and random error.
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(page number not for citation purposes)If it is true that s-sites are always bound in oligomers and
never bound in monomers, dNTP access to hexamer
s-sites, as is needed for RNR control, implies that either
the monomer-dimer-tetramer-hexamer equilibrium is
rapid enough that changes in ligand bound to the s-site
can occur via the monomer-dimer equilibrium, or
perhaps the hexamer stabilizes internal dimers enough
that hexamer s-sites can vacate without hexamer decom-
position. The latter case would complicate the analysis as
the term R
6X
9 for example might then describe more
than 3 filled a-sites.
Regarding a-b e f o r eh-site filling, since a-sites are known
to exist [16] and h-sites are in question, this is a
reasonable default. The alternative, to assume h-site
existence and instead challenge a-site existence, is much
less reasonable.
The most important short time constant (i.e. allosteric)
feedback control of RNR is via dATP. This statement is
based on ATP being too broadly used in cells for its level
to be manipulated to control dNTP supply, and dTTP
and dGTP being only selectivity controllers while when
dATP controls selectivity, it also closes a large positive
feedback loop that threads through dTTP and dGTP in
series, see Fig 1). This may help dNTP pools fill
uniformly and rapidly at the onset of S-phase. Once
the dNTP pools are filled, dATP also has the responsi-
bility of shutting off its s-site mediated positive feedback
loop through a-site mediated inhibition of all four
reaction rates (note that this argues in favor of dATP
Table 1: The top 3 models (lowest AIC) of the RX model space
Model Parameter Initial Value Optimal Value Confidence Interval
1 IIIIIIIIIIIJIIIIIIIIIIIIIIIII R6X8 100.000^13 63.101^13 (59.878^13, 66.175^13)
SSE 840487.830 7726.693
AIC 211.573 141.234
CPU 0.000 3.465 fit succeeded
2 IIIIIJIIIIIJIIIIIIIIIIIIIIIII R2X4 100.000^5 432.997^5 (311.064^5, 601.845^5)
R6X8 100.000^13 62.796^13 (59.878^13, 66.175^13)
SSE 778605.476 6873.411
AIC 213.608 142.660
CPU 0.000 5.302 fit succeeded
3 IIIIIIIIIIIIJIIIIIIIIIIIIIIII R6X9 100.000^14 70.367^14 (66.686^14, 74.228^14)
SSE 841284.881 8624.411
AIC 211.588 142.883
CPU 0.000 2.903 fit succeeded
Figure 9
Model limits at large ligand concentrations.I nt h e
second model in Fig. 8 and Table 1 (solid line here) the dimer
term R2X4 causes a below expectation peak (510 instead of
540)athigh[ATP].Inthelimitofveryhigh[ATP],thismodelis
dominated by the R2X4 term (average mass approaches
180 kDa) because this term partitions more X into a bound
state with R than the hexamer R6X8, i.e. 4/2 = 2 > 8/6 = 1.3.
These ratios are both 1.5 in the model R2X3.R6X9 (dashed
line) which has a balanced population in this limit (with a
limitingaveragemassof523kDa).Theseratiosare1.5and2in
the model R2X3.R6X12 (dotted) which yields pure hexamers
(average mass = 540 kDa) in the limit of infinite ATP.
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(page number not for citation purposes)binding the s-site more tightly than the a-site). This
picture suggests that prompt a-site mediated inhibition
in response to changes in [dATP] is important since
without a rapid response, the s-site mediated dATP
positive feedback loop may cause [dATP] overshoot.
Given that [dATP] << [ATP] implies that dATP collisions
with a-sites are much rarer than ATP a-site collisions,
when they do occur, it would help the circuit respond
r a p i d l yi fa tl e a s th a l fo ft h et i m et h es i t ew a se m p t ya n d
thus ready to be filled. This leads to interesting
speculations: R1 hexamers may have two types of a-
sites, one for ATP and one for dATP, and beyond ligand
differences, with this view (Fig. 12) dATP inhibition
versus ATP activation could in part be due to differences
in binding pockets of the two types of a-sites. Indeed,
this may be the reason that R1 hexamers exist.
The approach used selects model terms (and thus
parameters) based on how needed they are to explain
the data analyzed. If, in solution, hexamers rarely have
more than 3 ATPs bound to their a-sites, no parameters
are allocated to complexes with higher numbers of
bound ATP. The analysis presented does not claim that
≥ 3 a-sites will remain unoccupied under R1 crystal-
lization conditions that may differ greatly from those
used to generate the data analyzed here.
For the data analyzed, [RT]i s7μM (i.e. yielding up to
21 μM of ATP binding sites if h-sites exist) and the
minimum [XT]i s4 6μM, so the approximation [X] = [XT]
would not have been valid for this lowest [ATP] data
point. The value of such approximations is less with ≥ 2
oligomerization states than with one (which has an
Figure 10
Normalized model number densities of AICs of models with SSEs less than twice the minimum SSE and
monotonic non-decreasing ratios of ATP per R1 as oligomer sizes increase. A) T h ec o m p l e t es e to fs u c hm o d e l s .
B) The 1- and 2-parameter models. C) The 3-parameter models. D) Models with singular Hessians. In all cases a difference in
h-site hypothesis densities is supported by a two-sample Kolmogorov-Smirnov test, P < 10
-15 ( A ,C ,D )a n dP<2×1 0
-5 (B).
Compare to Fig. 6.
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(page number not for citation purposes)analytic solution, see accompanying paper), as the
univariate polynomial that results still requires a
numerical solution (e.g. [X] = [XT]i nE q .( 5 )y i e l d sa
6
th order polynomial in free [R]), but univariate
polynomials are solved much faster than multivariate
polynomials, e.g. using ODEs as in Eq. (3), so the
computational savings are worthwhile if the approxima-
tion is tolerable. For the data used here, as [X] = [XT]i s
valid for most of the data points, this approximation
caused deviations of only 1% in the parameter estimates
of Table 1 but it gave a 30-fold increase in computation
speed.
Since there were 13, 286 and 3094 K infinity spur graphs
w i t h1 ,2o r3p a r a m e t e r s ,c o m p a r e dt o0 ,2a n d1 5K
equality grid graphs, and since models with few
parameters have an AIC advantage when dataset sizes
are modest, it is not surprising that with 15 data points,
the top models were all spur models. In the future, as
automation affords richer datasets, grid graphs may
become more competitive. Thus, though the grid graph
enumeration efforts expended in this paper did not pay
immediate dividends, they may in the future.
Contiguous stretches of equal binary K parameters
within threads were not explored because binary K
models were already non-competitive due to over-
parameterization, and because additional ATP ligands
on a j-mer would not have changed DLS masses
detectably, so K cooperativity within threads would not
have been detectable.
Microfluidic chip technology [28-31] will eventually
enable 5-dimensional RNR studies where [ATP] and
Figure 11
The 13 single-edge spur models of Fig. 7(A) with p (B), M1 (C) or both (D) estimated. The plots show that R
6X
9
should perhaps be trusted more than R
6X
8. AICs in the B-D legends suggest that R
6X
10 (which allows a 4
th filled a-site) is more
likely than R
6X
7.
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(page number not for citation purposes)[NDP]s are fixed to in vivo levels and [R1], [R2], [dATP],
[dTTP] and [dGTP] vary across ranges centered about
physiological operating points. If ccems can automati-
cally analyze new RNR data as it arrives, it could find
uses in sequential experimental designs [32] where the
chip conditions of the next measurements are deter-
mined in real time to implement efficient 5-D sampling
strategies.
As protein expression and purification core facilities
become more common, reconstituted network analyses
where alleged protein-protein interactions are mathema-
tically characterized for applications in systems biology
[33,34] will eventually also become more common. It is
anticipated here that many of these interactions will be
combinatorially complex and that ccems will then find
broader uses.
Conclusion
No terms higher than R
6X
9 were needed to explain the
ATP induced R1 hexamerization data found in figure 1 of
reference [20]. This suggests that under the experimental
conditions of this dataset, ~1/2 of the hexamer a-sites are
not bound by ATP, and that if a-sites fill before h-sites,
that h-sites need not exist to explain this dataset.
The R package ccems currently solves 2-reactant pro-
blems where total reactant concentrations are known
and manipulated, free reactant concentrations are
determined by a system of mass action-based total
concentration constraint polynomials, expected mea-
surements are determined by model predicted complex
concentrations, and the number of models is large due to
combinatorial complexity. This is a generic in vitro
synthetic biochemical system problem statement, so
ccems could have a broad impact.
Methods
Data were digitized by plotDigitizer [35] and analyzed
using ccems[22]. Hessians of SSEs obtained using optim
were divided by 2, inverted, multiplied by SSE/(N - P),
and the square roots of the main diagonal were then
multiplied by 1.96 to form 95% Wald CI. Parameters
were estimated in exponentiated forms to constrain
them to positive values.
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Reviewer’sc o m m e n t s
Reviewer’sr e p o r t1
Ossama B. Kashlan, University of Pittsburgh (nominated by
Philip Hahnfeldt, Tufts)
As you’ve shown, you don’tn e e dt oi n v o k et h eh-site to
fit our figure 1 data. But we did need it for the other data
in the paper, e.g. the global fit of DLS and activity data in
figure 5 of our paper (with dTTP saturating the s-site).
Since we wanted to use a single model for all the data,
we therefore used an h-site to fit our figure 1 data. You
should include a discussion of the potential of the h-site-
less models to account for our figure 5 DLS data (as you
n o t e d ,m o d e l i n ga c t i v i t yd a t ag reatly increases the model
space).
Radivoyevitch’sR e s p o n s e
L e tu sd e n o t eb yRt h ed i m e rc o m p l e x
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and in this case, the top 3 models are R
2X
7 +R
3X
12,
R
2X
5 +R
3X
9 and R
2X
6 +R
3X
10 +R
3X
12,i . e .m o d e l sw i t h
h-site terms. Thus, you are indeed correct that there
appears to be evidence for an h-site in your figure 5 (of
Figure 12
R1 hexamer model. R1 hexamer formation could result in
the creation of two types of a-sites.
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(page number not for citation purposes)r e f[ 2 0 ] )d a t a .F i t so ft h e s em o d e l sa r es h o w ni nt h en e w
Fig. 13. If I remove the three datapoints with [ATP] =
5 mM, 7 mM and 10 mM, i.e. values higher than those in
your figure 1 data, similar results are obtained. Thus,
perhaps the h-site is created by the presence of bound
GDP substrate, or bound dTTP, or both, but yes,
different inferences are drawn from your figure 1 and 5
datasets when they are analyzed individually. It should
perhaps be noted that all of the tetramer terms above
also have occupied h-sites, and that the model that you
used did not, i.e. the methods presented may have value
in analyses of your figure 5 data as well. Further, since no
1-parameter models were among the top 100, they likely
all yielded poor fits.
Kashlan’sR e s p o n s e
As you concluded from the DLS data with saturating
dTTP, an h-site is necessary to fit this data. However, I
find your interpretation that the presence of GDP and/or
dTTP possibly creates the h-site to be unlikely. More
likely is that ligands bound to one site have heterotropic
binding effects on the other sites. Under this logic, the
underlying binding K’s for ATP in the absence of GDP
and dTTP are such that the DLS data under these
conditions lack the complexity to require the invocation
of an h-site. However, in the presence of GDP and dTTP,
the underlying K’s are such that this complexity is
unmasked. I also have a few additional comments:
1. Regarding the assumption that s- fills before a- fills
before h-site, and that oligomers always have certain
sites filled. This assumption ignores a few important
observations and possibilities. First is the ability of
R1 to dimerize in the absence of a filled s-site, e.g. we
observed that CDP reduction occurs (at a low rate) in
the absence of an s-site ligand. Second, as you
pointed out, is the ability to switch s-site ligands
while the a- (and/or h-) site(s) are occupied. This is
important, because you base your conclusion of a
lack of h-site evidence on the fact that not enough
ATP are bound to fill the a-sites. But unless h-site
b i n d i n gi sd r a m a t i c a l l yw e a k e rt h a na-site binding,
binding the first few h-sites may be more favorable
than filling the last few a-sites.
2. The minimal models presented as ‘best’, and from
which physical conclusions are drawn, should be able
to account for both (all) datasets. Having a different
model framework for each given set of ligands adds a
new level of complexity. Can you combine the AIC
scores for the fits to both sets of data to find the best
model(s), based at least on these data?
3. The conclusion on p. 3 should be edited to reflect
the above comments and your response to my
previous comment.
4 .T h eb a c k g r o u n do np .3s h o u l db ee d i t e dt or e a d ,
“ATP binds to both of these sites and there is some
evidence, based on RNR *mass and* activity versus
[ATP] data.”
Radivoyevitch’sR e s p o n s e
Two comments: 1) if we let site creation include
increasing the affinity so that an infinite K is now finite,
we may be saying the same things; and 2) you have 9
data points in your figure 5 and 16 in your figure 1, and
it would have been better to have these sample numbers
reversed if indeed the conditions of your figure 5 yield
more complex data. My inclination is to trust a
1-parameter model fitted to 15 points more than a
2-parameter model fitted to 9. Regarding your other two
remarks:
1. By stating model assumptions I did not mean to say
that I thought they must be true (no model is ever
correct). What I meant to say is that my inferences are
all conditional on their truth. The situation is such
that unless such an assumption is made about the
binding order, the meaning of a polynomial term that
exists in a model is ambiguous. This is a big weakness,
but I do not see any way around it. I now state this
weakness at the end of the Limitations Section.
Figure 13
Fits of the top 3 models with [dTTP] and [GDP] at
saturating levels. In response to reviewer Kashlan’s
comment, the top 3 models of the data in figure 5 of his
paper are shown. All models yield m = 180 at [ATP] = 0;
m = 181 was measured.
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(page number not for citation purposes)2. Note that we really have two different hub proteins
for these two datasets, one with R as R1 monomer
and the other with R as dTTP and GDP saturated R1
dimer. All complete K parameters downstream of
these two hubs would thus be independent and there
would thus be no way to pool the parameter
estimates (beyond the error estimate). The joint
model would thus be the sum of the terms.
3. The conclusion in the abstract has been softened to
reflect conditionality on the experimental conditions
of your figure 1 dataset.
4. Agreed, but this sentence no longer exists.
Reviewer’sr e p o r t2
Bin Hu, Los Alamos National Laboratory (nominated by
William Hlavacek, LANL)
In this work, the author did a theoretical study on the
equilibrium of ATP-induced hexamerization of the R1
subunit of ribonucleotide reductase (RNR), where
combinatorial complexity is observed. Statistical hypoth-
eses with assumptions were used to generate an array of
models of the hexamerization process. Statistical com-
parison of the model structures suggests that a-sites may
not be occupied by ATP in R1 hexamers at physiological
ATP concentrations and the h-site may not exist. Results
from this work suggest that the work in reference [20]
did not consider the possibility of a-sites not being
occupied, which allows the authors in [20] to suggest
that the h-site exists. A final judgment about whether the
h-site exists; however, can only be reached through
additional experimental work. Although the statistical
analysis approach used in this work is interesting, the
author may wish to add a discussion comparing results
from this work to those of Ref [20]. Minor comments are
as follows:
1. An introduction to RNR, its function and regula-
tion is needed. Currently there is only one sentence
in the beginning of the Introduction about RNR.
2. It is not mentioned in the paper how the R1
subunit forms RNR with R2 units and what kind of
multimers the R1 subunit can form and their
biological importance. References, especially for the
crystallography data, are needed.
3. In the Results section, the meaning of “complete
dissociation constants” is not clear.
4. The R package ccems was first introduced without
reference.
5. The author submitted two papers to this journal
simultaneously. Instead of using “the accompanying
paper,”theauthororeditorialofficemaywanttochange
it to some other description that may help readers to
find out which paper the author is referencing.
6. I cannot tell whether the assumption “s-sites are
always filled in oligomers and never filled in
monomers” is acceptable in this study.
7. It would be interesting if the author compared the
parameters used this work with those used in [20].
Radivoyevitch’s Responses
The model of ATP induced R1 hexamerization previously
proposed by Kashlan et al. [20] assumed: a) that the
binary dissociation constants K of the ATP binding sites
s, a and h are the same within oligomers (within site
types); b) that these Ks, Ka and Kh are infinite in
structures smaller than dimers, tetramers and hexamers,
respectively (note that all three are thus infinite in
monomers); c) that finite K are equal wherever it is
plausible that they might be, i.e. that Ka in tetramers
equals Ka in hexamers and that Ks i st h es a m ea c r o s s
dimers, tetramers and hexamers; d) that the dissociation
constants for R1 binding to itself (KR_R), R1 dimers
binding to themselves (KR2_R2), and R1 tetramers
binding to R1 dimers (KR4_R2), are independently
adjustable; and e) that R1 tetramers can isomerize with
an isomerization constant Kis. Assumptions a) to c)
constrain the model and d) to e) broaden it. When
Kashlan et al. fitted their model to their DLS data, KR_R,
KR2_R2, KR4_R2 and Kis were treated as being independent
of R1 ligands, and consistent with these assumptions, the
data in their figures 1 and 3-9 were fitted to single values
of these constants such that the fits in these figures did
not appear too poor). With respect to their figure 1 data,
however, the first five residuals of their fit were negative
and thus correlated, and although the residuals were
small and thus subtle, the fit was thus poor. This paper
focuses on their figure 1 data alone.
Regarding proof that an h-site does or does not exist, I
agree that binding studies must be performed to see how
many ATPs actually bind to R1, but such studies may be
difficult, as evidenced by the fact that they have not yet
been performed. My hunch is that experimental chal-
lenges are associated with weak ATP binding and thus
the high [ATP] needed to achieve binding, which may
make changes in free [ATP] due to free ATP losses to ATP
bound to R1 difficult to detect. Regarding comparisons
of results, since the single model that they fitted to their
DLS data was also based on their RNR activity data, and
since activity data is much more complicated to analyze
than mass data because conjectures about different
activity parameters being zero or equal to each other
greatly expands the model space further, and since my
software is not yet ready for more than one type of
oligomer in activity data analyses (in the accompanying
paper the enzyme TK1 was strictly tetrameric), our results
cannot be compared. Regarding your points:
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(page number not for citation purposes)1. Background material regarding dNTP supply and
RNR have now been added to the Introduction.
However, since I do not model RNR activity data, this
work has limited relevance to dNTP supply metabo-
lism. My focus is thus on the methods developed.
Indeed, it may be best to view R1 as merely some
protein that has either 2 or 3 binding sites on it for a
ligand that induces its hexamerization.
2. A) R2 is irrelevant here since this paper does not
delve into activity data and since R2 was not present in
the experiment that yielded the DLS average mass data
analyzed. B) The first eukaryotic (yeast) R1 structure
showed a dimer and this was referenced [26]. Though a
dATP induced R1 tetramer was observed in Ref [20], it
was not observed in [27], and no lab has observed it
directly using the more relevant ligand (for this paper)
ATP. Thus, tetramers could perhaps have been left out
of the model space, but there is strong support for R1
monomers (e.g. the low [ATP] DLS data in Fig. 7),
dimers (the structure in [26]) and hexamers (e.g. the
high [ATP] DLS data in Fig. 7).
3. By complete dissociation constants I mean those
where the Gibbs Free energies are with respect to all
reactants being completely separated from one
another by infinite distances. In contrast, by binary
dissociation constants I mean situations where only
one reactant (or perhaps a subcomplex) is separated
out at infinity while all of the other reactants remain
bound together.
4. The link to my ccems page is now referenced
earlier.
5. They should end up back-to-back and I hope
readers will read, and know of, both.
6. The conclusions remain the same if I drop h-site
terms and blow up the model space by introducing s-
site terms, i.e. there is some support for the
assumption besides dTTP induced R1dimerization
results in [25] and the structure in [26].
7. The model used in [20] has 7 parameters. Their
binary K values for ATP binding were 100 μMf o r
dimers and tetramers and 1.1 mM for hexamers. For
R1 oligomerization and isomerization their values
were KR_R = 170 μM, KR2_R2 = 2-5 mM, KR4_R2 =
2-6 mM and Kis = 10-40 where ranges depend on
different tetrameric activity assumptions. Without the
same parameters in my models, comparisons are
difficult. The best model in Table 1 is R6X8 and it has
a geometric mean binary binding constant of 63 μM.
Figure 14
ccems code example. These codes generate Table 1 and the RX model space used in this paper.
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(page number not for citation purposes)Since all of the binary K values of [20] are ≥ 100 μM,
their geometric mean must also be ≥ 100 μM. Indeed,
aassuming ATP fills 6 s-sites and 2 a-sites in R6X8,
one obtains a geometric mean binary K of 190 μM=
((100)
8(170)
3(3000)
1(3000)
1)
1/13,i . e .t h e r ei sa
difference of a factor of 3 in parameter estimates
between analyses.
Reviewer’sr e p o r t3
Rainer K. Sachs, UC Berkeley
In general, is there some systematic rationale and/or
underlying reasoning on what criteria to use to distin-
guish hypotheses? Do you estimate that almost any
criterion would give the same final answers qualitatively?
How did you decide on 30 models in your comparison
of model proportions? What is your main motivation to
study RNR? Can your software handle more than two
reactants? Can you provide a code use example?
Radivoyevitch’s Responses
T h eA I Cw a su s e d( w i t h o u tc o n s i d e r a t i o no fa l t e r n a t i v e s
such as the Bayesian Information Criterion, BIC) only
because it is the most popular. The idea was to pick a
criterion to present my main contribution, which is in
model space generation rather than model selection.
Though there may be reasons to switch to a different
c r i t e r i o nt h a tIh a v ey e tt ol e a r no f ,i nt h ei n t e r i m ,t h e
AIC is my default. I suspect that the conclusions made
here would be robust to such changes.
The choice of 30 models involved data snooping as you
may have guessed, i.e. 30 looked like a good breaking
point for a claim that the data does not support an h-site.
Thus, the difference in proportions p-value that I
reported may be overly significant. Nevertheless, the
Kolmogorov-Smironov Test is with respect to entire
distributions in Fig. 6, so the conclusion that this
particular dataset does not demand the existence of an
h-site is robust. There is no indication that this
conclusion will hold under different experimental
c o n d i t i o n s ,h o w e v e r ,e . g .s e eK a s h l a n ’s review above.
Three paragraphs were added to the Introduction to
motivate RNR research. The automated model space
generation capabilities of ccems are indeed limited to
two reactants and this is now stated in the title and
elsewhere. If R and ccems are installed, the R command
load(ccems) followed by ?ccems yields help which
includes the code example in Fig. 14 which can be
pasted into the R command line to create the model
space used here.
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